Conclusion. These results revealed that liraglutide could improve myofibril and mitochondria injury in skeletal muscle against T2DM via PTP1B and PI3K/Akt2 signaling pathway. This evidence concerns the gene PTPN1 and type 2 diabetes mellitus.